Edition:
United Kingdom

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

41.68USD
16 Nov 2018
Change (% chg)

$2.13 (+5.39%)
Prev Close
$39.55
Open
$39.90
Day's High
$42.90
Day's Low
$39.78
Volume
442,881
Avg. Vol
188,465
52-wk High
$50.00
52-wk Low
$26.22

Chart for

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $1,019.33
Shares Outstanding(Mil.): 39.22
Dividend: --
Yield (%): --

Financials

  ARNA.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -0.59 -- --
ROI: -13.16 -0.64 15.05
ROE: -39.77 0.08 16.62

Arena Pharma soars on deal with United Therapeutics for hypertension drug

Shares of Arena Pharmaceuticals Inc jumped nearly 30 percent after the drug developer sold rights to develop and sell its hypertension treatment to United Therapeutics Corp, fetching it $800 million in an upfront payment.

15 Nov 2018

Earnings vs. Estimates